HBM Healthcare Investments (SW:HBMN) — Market Cap & Net Worth
Market Cap & Net Worth: HBM Healthcare Investments (HBMN)
HBM Healthcare Investments (SW:HBMN) has a market capitalization of $1.53 Billion (CHF1.21 Billion) as of August 1, 2026. Listed on the SW stock exchange, this Switzerland-based company holds position #7019 globally and #100 in its home market, demonstrating a 2.04% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying HBM Healthcare Investments's stock price CHF250.50 by its total outstanding shares 6576639 (6.58 Million). See capital reinvestment ratio of HBM Healthcare Investments to understand how much of operating cash flow is reinvested back into capital assets.
HBM Healthcare Investments Market Cap History: 2015 to 2026
HBM Healthcare Investments's market capitalization history from 2015 to 2026. Data shows growth from $586.36 Million to $2.08 Billion (13.28% CAGR).
HBM Healthcare Investments Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how HBM Healthcare Investments's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
84.18x
HBM Healthcare Investments's market cap is 84.18 times its annual revenue
Latest Price to Earnings (P/E) Ratio
101.57x
HBM Healthcare Investments's market cap is 101.57 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $603.13 Million | $27.23 Million | $23.81 Million | 22.15x | 25.34x |
| 2017 | $854.23 Million | $142.41 Million | $136.77 Million | 6.00x | 6.25x |
| 2018 | $1.04 Billion | $121.09 Million | $115.87 Million | 8.59x | 8.98x |
| 2019 | $1.55 Billion | $213.07 Million | $182.70 Million | 7.27x | 8.48x |
| 2020 | $2.19 Billion | $186.19 Million | $182.70 Million | 11.74x | 11.96x |
| 2021 | $2.52 Billion | $766.31 Million | $756.27 Million | 3.28x | 3.33x |
| 2022 | $1.55 Billion | $-76.50 Million | -$78.03 Million | -20.24x | N/A |
| 2023 | $1.46 Billion | $-142.25 Million | -$146.32 Million | -10.26x | N/A |
| 2024 | $1.46 Billion | $3.08 Million | -$1.08 Million | 475.74x | N/A |
| 2025 | $1.88 Billion | $22.37 Million | $18.54 Million | 84.18x | 101.57x |
Competitor Companies of HBMN by Market Capitalization
Companies near HBM Healthcare Investments in the global market cap rankings as of August 1, 2026.
Key companies related to HBM Healthcare Investments by market ranking:
- BlackRock Inc (NYSE:BLK): Ranked #135 globally with a market cap of $167.86 Billion USD.
- Brookfield Corporation (TO:BN): Ranked #266 globally with a market cap of $96.74 Billion USD ( CA$133.73 Billion CAD).
- Blackstone Group Inc (NYSE:BX): Ranked #270 globally with a market cap of $94.90 Billion USD.
- KKR & Co. Inc. (NYSE:KKR): Ranked #291 globally with a market cap of $89.37 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #135 | BlackRock Inc | NYSE:BLK | $167.86 Billion | $1090.39 |
| #266 | Brookfield Corporation | TO:BN | $96.74 Billion | CA$59.58 |
| #270 | Blackstone Group Inc | NYSE:BX | $94.90 Billion | $127.75 |
| #291 | KKR & Co. Inc. | NYSE:KKR | $89.37 Billion | $101.43 |
HBM Healthcare Investments Historical Marketcap From 2015 to 2026
Between 2015 and today, HBM Healthcare Investments's market cap moved from $586.36 Million to $ 2.08 Billion, with a yearly change of 13.28%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CHF2.08 Billion | +10.60% |
| 2025 | CHF1.88 Billion | +28.69% |
| 2024 | CHF1.46 Billion | +0.24% |
| 2023 | CHF1.46 Billion | -5.70% |
| 2022 | CHF1.55 Billion | -38.46% |
| 2021 | CHF2.52 Billion | +15.09% |
| 2020 | CHF2.19 Billion | +41.04% |
| 2019 | CHF1.55 Billion | +48.96% |
| 2018 | CHF1.04 Billion | +21.79% |
| 2017 | CHF854.23 Million | +41.63% |
| 2016 | CHF603.13 Million | +2.86% |
| 2015 | CHF586.36 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 1st, 2026 the market cap of HBM Healthcare Investments was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.53 Billion USD |
| MoneyControl | $1.53 Billion USD |
| MarketWatch | $1.53 Billion USD |
| marketcap.company | $1.53 Billion USD |
| Reuters | $1.53 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About HBM Healthcare Investments
HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds… Read more